A review of adjuvants for Leishmania vaccine candidates
Open Access
- 1 January 2010
- journal article
- review article
- Published by Elsevier in Journal of Biomedical Research
- Vol. 24 (1) , 16-25
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Prophylactic Efficacy of High‐Molecular‐Weight Antigenic Fractions of a Recent Clinical Isolate of Leishmania donovani Against Visceral LeishmaniasisScandinavian Journal of Immunology, 2008
- Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4+T CellsInfection and Immunity, 2007
- Safety and Enhanced Immunogenicity of a Hepatitis B Core ParticlePlasmodium falciparumMalaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I TrialInfection and Immunity, 2005
- Immunization withLeishmania majorExogenous Antigens Protects Susceptible BALB/c Mice against Challenge Infection withL. majorInfection and Immunity, 2004
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- IL-12: Initiation Cytokine for Cell-Mediated ImmunityScience, 1993
- Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.Journal of Experimental Medicine, 1992
- Sternal abscess as a complication of BCG-revaccinationTubercle, 1988
- Mycobacteria and autoimmunityImmunology Today, 1988